These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21288627)

  • 1. Comparison of the efficacy of low anterior resection with primary anastomosis and Hartmann's procedure in advanced primary or recurrent epithelial ovarian cancer.
    Kim HS; Kim EN; Jeong SY; Chung HH; Kim YB; Kim JW; Park KJ; Park NH; Song YS; Park JG; Kang SB
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):194-8. PubMed ID: 21288627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of bowel continuity after surgery for acute perforated diverticulitis: should Hartmann's procedure be considered a one-stage procedure?
    Vermeulen J; Coene PP; Van Hout NM; van der Harst E; Gosselink MP; Mannaerts GH; Weidema WF; Lange JF
    Colorectal Dis; 2009 Jul; 11(6):619-24. PubMed ID: 18727727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hartmann's reversal is associated with high postoperative adverse events.
    Aydin HN; Remzi FH; Tekkis PP; Fazio VW
    Dis Colon Rectum; 2005 Nov; 48(11):2117-26. PubMed ID: 16228835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
    Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
    Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
    Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN
    J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and morbidity of reversal of Hartmann's.
    Banerjee S; Leather AJ; Rennie JA; Samano N; Gonzalez JG; Papagrigoriadis S
    Colorectal Dis; 2005 Sep; 7(5):454-9. PubMed ID: 16108881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative colonic lavage with primary anastomosis vs. Hartmann's procedure for perforated diverticular disease of the colon: a consecutive study.
    Regenet N; Tuech JJ; Pessaux P; Ziani M; Rouge C; Hennekinne S; Arnaud JP
    Hepatogastroenterology; 2002; 49(45):664-7. PubMed ID: 12063965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical practices for malignant left colonic obstruction in Germany.
    Kube R; Granowski D; Stübs P; Mroczkowski P; Ptok H; Schmidt U; Gastinger I; Lippert H;
    Eur J Surg Oncol; 2010 Jan; 36(1):65-71. PubMed ID: 19747795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of Hartmann's operation as an emergency intervention in sigmoid diverticulitis].
    Röthlin M; Rietschi G; Largiadèr F
    Swiss Surg; 1997; 3(3):107-11. PubMed ID: 9264856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complication rates after Hartmann's reversal: open vs. laparoscopic approach.
    Haughn C; Ju B; Uchal M; Arnaud JP; Reed JF; Bergamaschi R
    Dis Colon Rectum; 2008 Aug; 51(8):1232-6. PubMed ID: 18512101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
    Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS
    Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?
    Zang RY; Li ZT; Tang J; Cheng X; Cai SM; Zhang ZY; Teng NN
    Cancer; 2004 Mar; 100(6):1152-61. PubMed ID: 15022281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
    Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
    Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of ovarian cancer patients who underwent incomplete surgical staging.
    Panprom P; Lertkhachonsuk R
    J Med Assoc Thai; 2008 Sep; 91(9):1323-30. PubMed ID: 18843859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectosigmoid resection without colostomy during primary cytoreductive surgery for ovarian carcinoma.
    Sonnendecker EW; Beale PG
    Int Surg; 1989; 74(1):10-2. PubMed ID: 2707991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency operation in carcinomas of the left colon: value of Hartmann's procedure.
    Meyer F; Marusch F; Koch A; Meyer L; Führer S; Köckerling F; Lippert H; Gastinger I;
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s226-9. PubMed ID: 15655630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
    Chi DS; Eisenhauer EL; Lang J; Huh J; Haddad L; Abu-Rustum NR; Sonoda Y; Levine DA; Hensley M; Barakat RR
    Gynecol Oncol; 2006 Nov; 103(2):559-64. PubMed ID: 16714056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morbi-mortality after Hartmann procedure for peritonitis complicating sigmoid diverticulitis. A retrospective analysis of 85 cases].
    Dumont F; Vibert E; Duval H; Manaouil D; Sredic A; Alfahel N; Mauvais F; De Fresnoy H; Rudant J; Katsahian S; Riboulot M; Galy C; Verhaeghe P; Dupont H; Regimbeau JM
    Ann Chir; 2005; 130(6-7):391-9. PubMed ID: 15982629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
    Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM
    Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.